A detailed history of Aevitas Wealth Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Aevitas Wealth Management, Inc. holds 5,752 shares of AMGN stock, worth $1.84 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
5,752
Previous 5,740 0.21%
Holding current value
$1.84 Million
Previous $1.29 Million 16.69%
% of portfolio
0.89%
Previous 0.97%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

BUY
$229.03 - $291.01 $2,748 - $3,492
12 Added 0.21%
5,752 $0
Q3 2022

Oct 24, 2022

SELL
$224.46 - $253.15 $25,588 - $28,859
-114 Reduced 1.95%
5,740 $1.29 Million
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $7,152 - $7,958
31 Added 0.53%
5,854 $1.42 Million
Q1 2022

Apr 25, 2022

SELL
$219.27 - $242.57 $65,781 - $72,771
-300 Reduced 4.9%
5,823 $1.41 Million
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $4,176 - $4,779
21 Added 0.34%
6,123 $1.38 Million
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $4,033 - $4,725
-19 Reduced 0.31%
6,102 $1.3 Million
Q2 2021

Jul 22, 2021

BUY
$233.58 - $259.14 $97,402 - $108,061
417 Added 7.31%
6,121 $1.49 Million
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $8,876 - $10,344
-40 Reduced 0.7%
5,704 $1.42 Million
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $14,281 - $17,006
66 Added 1.16%
5,744 $1.32 Million
Q3 2020

Oct 22, 2020

BUY
$234.65 - $260.95 $3,050 - $3,392
13 Added 0.23%
5,678 $1.44 Million
Q2 2020

Jul 29, 2020

BUY
$197.81 - $242.74 $3,164 - $3,883
16 Added 0.28%
5,665 $1.34 Million
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $18,224 - $24,170
-100 Reduced 1.74%
5,649 $1.15 Million
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $5,865 - $7,539
31 Added 0.54%
5,749 $1.39 Million
Q3 2019

Oct 21, 2019

BUY
$174.11 - $208.62 $54,496 - $65,298
313 Added 5.79%
5,718 $1.11 Million
Q2 2019

Jul 26, 2019

BUY
$166.7 - $195.41 $9,501 - $11,138
57 Added 1.07%
5,405 $996,000
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $11,394 - $12,844
63 Added 1.19%
5,348 $1.02 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $2,140 - $2,499
12 Added 0.23%
5,285 $1.03 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $22,049 - $24,857
119 Added 2.31%
5,273 $1.09 Million
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $1,328 - $1,492
8 Added 0.16%
5,154 $951,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $17,959 - $20,988
-106 Reduced 2.02%
5,146 $877,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $886,485 - $990,474
5,252
5,252 $913,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aevitas Wealth Management, Inc. Portfolio

Follow Aevitas Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.